Evidence map›Paper›PMID 28533239›Full record

ArticleAntimicrobial agents and chemotherapy2017

Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.

Grennady Wirjanata, Irene Handayuni, Pak Prayoga, Leo Leonardo, Dwi Apriyanti, Leily Trianty, Ruland Wandosa, Basbak Gobay, Enny Kenangalem, Jeanne Rini Poespoprodjo and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions.International journal for parasitology. Drugs and drug resistance · 2021
    Review
  3. Molecular detection of antimalarial drug resistance inPathogens (Basel, Switzerland) · 2020
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Grennady WirjanataGlobal and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, Darwin, Australia.
Irene HandayuniGlobal and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, Darwin, Australia.
Pak PrayogaPapuan Health and Community Development Foundation (PHCDF), Timika, Papua, Indonesia.
Leo LeonardoPapuan Health and Community Development Foundation (PHCDF), Timika, Papua, Indonesia.
Dwi ApriyantiEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Leily TriantyEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Ruland WandosaPapuan Health and Community Development Foundation (PHCDF), Timika, Papua, Indonesia.
Basbak GobayPapuan Health and Community Development Foundation (PHCDF), Timika, Papua, Indonesia.
Enny KenangalemPapuan Health and Community Development Foundation (PHCDF), Timika, Papua, Indonesia.
Jeanne Rini PoespoprodjoPapuan Health and Community Development Foundation (PHCDF), Timika, Papua, Indonesia.
Rintis NoviyantiEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Dennis E KyleDepartment of Global Health, University of South Florida, Tampa, Florida, USA.
Qin ChengAustralian Army Malaria Institute, Brisbane, Australia.
Ric N PriceGlobal and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, Darwin, Australia.
Jutta MarfurtGlobal and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, Darwin, Australia jutta.marfurt@menzies.edu.au.
State University of Papua · IDCharles Darwin University · AUEijkman Institute for Molecular Biology · IDQIMR Berghofer Medical Research Institute · AUUniversitas Gadjah Mada · IDUniversity of South Florida · US

Funding

Pharmacologic Approaches to Combating Resistance to Antimalarial CombinationsR01AI079709 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FIDOCK, DAVID A, KYLE, DENNIS E · 2008 to 2011
$2.3M
Wellcome Trust 099875Wellcome Trust 200909Wellcome Trust 200909/Z/16/Z
6 · The paper itself

Abstract

High-grade chloroquine (CQ) resistance has emerged in both

Indexed as

AntimalarialsChloroquineDrug ResistanceHumansIndonesiaMalaria, FalciparumMalaria, VivaxParasitic Sensitivity TestsPlasmodium falciparumPlasmodium vivaxAntimalarialsChloroquinechloroquinechloroquine resistance reversaldrug resistancemalariaPlasmodium falciparumPlasmodium vivax

Identifiers

PMID28533239
PMCPMC5527611
OpenAlexW2619901052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.